Burning Rock Biotech (BNR) Receivables - Net: 2020-2025
Historic Receivables - Net for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $25.8 million.
- Burning Rock Biotech's Receivables - Net rose 8.85% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 8.85%. This contributed to the annual value of $27.1 million for FY2024, which is 16.47% up from last year.
- As of Q3 2025, Burning Rock Biotech's Receivables - Net stood at $25.8 million, which was down 2.62% from $26.5 million recorded in Q2 2025.
- Burning Rock Biotech's 5-year Receivables - Net high stood at $27.1 million for Q4 2024, and its period low was $11.6 million during Q1 2021.
- Its 3-year average for Receivables - Net is $22.3 million, with a median of $22.0 million in 2025.
- Data for Burning Rock Biotech's Receivables - Net shows a peak YoY increase of 40.60% (in 2022) and a maximum YoY decrease of 0.14% (in 2022) over the last 5 years.
- Over the past 5 years, Burning Rock Biotech's Receivables - Net (MRQ) stood at $20.6 million in 2021, then rose by 7.52% to $22.2 million in 2022, then grew by 5.02% to $23.3 million in 2023, then grew by 16.47% to $27.1 million in 2024, then decreased by 4.74% to $25.8 million in 2025.
- Its Receivables - Net was $25.8 million in Q3 2025, compared to $26.5 million in Q2 2025 and $22.0 million in Q1 2025.